Amide surrogates are common in naturally occurring peptides and in synthetic peptides used in therapy. Whereas backbone-engineered proteins are, to date, extremely laborious to produce by genetic means,[1] the advent of chemoselective peptide chemical ligation reactions [2, 3] paved the way to such complex molecular architectures of considerable potential for protein therapeutics. To date, the most popular strategy to introduce amide ...
